학술논문
Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study
Document Type
Abstract
Author
Source
In Blood 8 December 2017 130 Supplement 1:1689-1689
Subject
Language
ISSN
0006-4971